Drugs Manufactured With A Forged License, FIR Lodged, Drugs Worth 23.93 Lakhs Seized

Hyderabad: Drugs Control Administration, Telangana, has detected a significant case of fraudulent activity within the pharmaceutical industry. An investigation conducted by DCA officials has revealed that Ovoid Pharmachem Pvt. Ltd., located at Plot No. 318, Subashnagar, Quthbullapur Mandal, Medchal-Malkajgiri District, engaged in the forgery of a drug manufacturing license.

VB Kamalasan Reddy (IPS), Director General, DCA Telangana said in a press release that “Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., was involved in the creation of a forged Drug Manufacturing license in Form-25, bearing No. TS/MFG2019-43319, L.Dis.No: 315995/TS/2022 dated: 05/07/2022, for certain drug products which were not authorized for the company by the Drugs Control Administration, Telangana. This unlawful activity was carried out with the intention to deceive drug regulatory authorities, pharmaceutical manufacturers, distributors, and the public.

Upon verification of the Drugs Control Administration, Telangana licensing database on the ODLS (Online Drug Licensing System) Portal, it has been confirmed that Ovoid Pharmachem Pvt. Ltd. created a fake drug licence for certain drug products.

DCA also detected that the firm manufactured and sold certain drug products under this fraudulent license. Drugs Control Administration officials seized stocks worth Rs. 23.93 lakhs, including 800 Kgs of Activated Charcoal 250 mg and Simethicone 80 mg Pellets.”

Drugs Control Administration, Telangana, has filed a complaint with the Jeedimetla Police Station. FIR No. 327/2024 has been registered on 05-04-2024 against Mr. Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., under Sections 420 (Cheating) and 468 (Forgery) of the Indian Penal Code (IPC).

It is imperative to emphasize that the manufacturing and sale of pharmaceutical products under forged licenses pose a significant threat to public health and safety. All manufacturers shall comply strictly with regulatory requirements and maintain the highest standards of ethical conduct.

Related Posts

PGIMS recalls drug amid probe into deaths

The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

NPPA list brings little relief: No price cut for 25% cancer drugs

Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes